. "The European First Episode Schizophrenia Trial (EUFEST): Rationale and design of the trial" . "NL - Nizozemsko" . "RIV/00216208:11150/05:00004778" . "0920-9964" . "RIV/00216208:11150/05:00004778!RIV08-MSM-11150___" . "Libiger, Jan" . . "1"^^ . . "The aim of the European First Episode Schizophrenia Trial (EUFEST) is to compare treatment with amisulpride, quetiapine, olanzapine and ziprasidone to a low dose of haloperidol in an unselected sample of first episode schizophrenia patients with minimal prior exposure to antipsychotics. At present, more than 400 patients have been recruited and randomized in the following countries: Austria, Belgium, Bulgaria, Czech Republic, Germany, France, Israel, Italy, the Netherlands, Poland, Rumania, Spain, Sweden and Switzerland: The study should be finished by the end of 2006 and it is expected that results will yield relevant clinical information with regard to the effectiveness of the second generation antipsychotics. This effort represents the first independently designed trans-European schizophrenia treatment trial." . "C\u00EDle: c\u00EDlem the European first episode schizopherenia trial (EUFEST) je porovn\u00E1n\u00ED l\u00E9\u010Dby amisulpridem, quetiapinem, olanzapinem a ziprasidonem s n\u00EDzk\u00FDmi d\u00E1vkami haloperidolu na vzorku pacient\u016F po prvn\u00EDm ataku schizofrenie, kte\u0159\u00ED maj\u00ED minim\u00E1ln\u00ED p\u0159edchoz\u00ED zku\u0161enosti s antipsychotiky. Do dne\u0161n\u00ED doby do studie vstoupilo v\u00EDce ne\u017E 400 pacient\u016F ze t\u011Bchto zem\u00ED: Rakousko, Belgie, Bulharsko, \u010Cesk\u00E1 republika, N\u011Bmecko, Francie, Izrael, It\u00E1lie, Holandsko, Polsko, Rumunsko, atd. Studie by m\u011Bla skon\u010Dit na konci roku 2006."@cs . "78" . . "520661" . "[32A540FE400C]" . . "Schizophrenia Research" . "The European First Episode Schizophrenia Trial (EUFEST): Rationale and design of the trial" . "S" . "10"^^ . . "11150" . "147;156" . . "The aim of the European First Episode Schizophrenia Trial (EUFEST) is to compare treatment with amisulpride, quetiapine, olanzapine and ziprasidone to a low dose of haloperidol in an unselected sample of first episode schizophrenia patients with minimal prior exposure to antipsychotics. At present, more than 400 patients have been recruited and randomized in the following countries: Austria, Belgium, Bulgaria, Czech Republic, Germany, France, Israel, Italy, the Netherlands, Poland, Rumania, Spain, Sweden and Switzerland: The study should be finished by the end of 2006 and it is expected that results will yield relevant clinical information with regard to the effectiveness of the second generation antipsychotics. This effort represents the first independently designed trans-European schizophrenia treatment trial."@en . . "The European First Episode Schizophrenia Trial (EUFEST): Rationale and design of the trial"@en . . . . . . "Evropsk\u00E1 studie u prvn\u00EDch epizod schizofrenie (EUFEST): zd\u016Fvodn\u011Bn\u00ED a z\u00E1m\u011Br studie"@cs . . . . . . . "20"^^ . "2-3" . "The European First Episode Schizophrenia Trial (EUFEST): Rationale and design of the trial"@en . . "Evropsk\u00E1 studie u prvn\u00EDch epizod schizofrenie (EUFEST): zd\u016Fvodn\u011Bn\u00ED a z\u00E1m\u011Br studie"@cs . "European; First; Episode; Schizophrenia; Trial; EUFEST; Rationale; design; trial"@en .